ARTICLE | Company News
Ista starts submitting Vitrase NDA
January 4, 2002 8:00 AM UTC
ISTA submitted to the FDA the non-clinical pharmacology and toxicology section of its NDA for Vitrase hyaluronidase enzyme formulation to treat severe vitreous hemorrhage. ISTA expects to report data ...